Search Results

Case Study - Subaru

Julie

“About six years………”The doctor kept speaking but the words evaporated into thin air as Julie quickly did mental math to figure out what ages her child…

Information for Active Awardees

Select your program page for information pertaining to your grant, including details on the reporting and payment processes and policies on leaves of …

Dr. Peter van Galen: CDP Fellow Achievement Award Winner

The winner of the first annual CDP Achievement Award in the Fellow category, along with $, to be used for LLS research, is Dr. Peter van Galen. Dr. v…

News Release

Caregiver Support May Lead To Better Outcomes For Both Patients And Caregivers

It goes without saying that cancer causes a great burden on the patient, but few consider the great burden it causes on the informal caregivers. An i…

Dr. Shannon Elf: CDP Special Fellow Achievement Award Winner

Dr. Shannon Elf, rising star in the blood cancer field, is a highly driven and compassionate investigator dedicated to the pursuit of new therapeutic …

Coordination of Distinct Pathways Drives AML in a Subset of Patients

Various cellular events may lead to cancer. These include DNA mutations that change a protein’s structure as well as alterations that change the way g…

The First Annual LLS CDP Achievement Award Winners

The Leukemia & Lymphoma Society (LLS) has supported junior investigators in blood cancer research for more than years through the Career Development …

Discovery Links Molecular Pathways for Therapeutic Possibilities In MPN

Cancer results from the malfunction or dysregulation of normal cellular processes. The dysregulation of two such processes (or pathways) that are part…

Sports Analytics Model Adapted to Improve Cancer Outcome Prediction

Outcome prediction is central to the care of cancer patients. Will the patient be at some point in the near future or succumb to the disease? Will th…

Genotyping of Transcriptomes: A Breakthrough Technology in Single-Cell Analysis

Though a patient’s cancer is treated as a single disease, it is made up of a diverse collection of cells that are related but may have distinct charac…

Age-Related AML Risk: An Exploration of Hematopoietic Stem Cell Epigenetics

The population of elderly people is increasing both in the United States and worldwide, and this increase presents challenges in addressing the medica…

Heather

Heather draws her inspiration from her good friend, who has been fighting 's Lymphoma for the past years and her college best friend who is a survivo…

Jennifer

In , - Jennifer took to the stage to accept The Leukemia & Lymphoma Society’s (LLS) “Employee of the Year” award for her mother, Teresa McVay, who had…

TAP Partner News During ASH: December 5-8 2020

Current and former TAP partners show off data during the virtual American Society of Hematology (ASH) meeting that took place from December -8th.

FDA Approves Vyxeos for Secondary Acute Myeloid Leukemia in Children

DUBLIN, March , - Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyx…

Blog

Publication of CPX-351 Clinical Data in 'Blood Advances': Phase 3 Post-Hoc Analyses

March , - (Vyxeos, daunorubicin and cytarabine liposome for injection) is a liposomal encapsulation of daunorubicin and cytarabine approved by the …

TAP Partner News During AACR: April 10-15 2021

Current and former TAP partners show off data during the virtual American Association for Cancer Research (AACR) meeting that took place from April -…